Recurrent prostate carcinoma Clinical Trials

Delta Trials indexes 61 clinical trials for Recurrent prostate carcinoma in its publicly accessible dataset. Of these, 6 enrolling participants at this time and 30 trials have reached completion. This research takes place spanning 893 research sites around the world. An additional 25 trials are in preparatory or other active non-recruiting stages. Since 2020, 5 trials were terminated, illustrating the dynamic nature of clinical research. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity has changed over time.